<table border="0" cellpadding="0" cellspacing="0" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 9 Established and Other Potentially Significant Drug Interactions with Ganciclovir  
			</caption>
<thead>
<tr>
<th stylecode="Lrule Rrule Toprule">Name of the Concomitant Drug </th>
<th align="center" stylecode="Lrule Rrule Toprule">Change in the Concentration of Ganciclovir or Concomitant Drug</th>
<th align="center" stylecode="Lrule Rrule Toprule">Clinical Comment</th>
</tr>
</thead>
<tbody>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> Zidovudine <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">↓ Ganciclovir<br/>↑ Zidovudine<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">Zidovudine and valganciclovir hydrochloride each have the potential to cause neutropenia and anemia<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> Probenecid <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">↑ Ganciclovir<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">Patients taking probenecid and valganciclovir hydrochloride should be monitored for evidence of ganciclovir toxicity<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule" valign="top"> Mycophenolate  Mofetil (MMF) <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">↔ Ganciclovir (in patients with normal renal function)<br/>↔ MMF (in patients with normal renal function)<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">Patients with renal impairment should be monitored carefully as levels of MMF metabolites and ganciclovir may increase<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule" valign="top"> Didanosine <br/>
</td>
<td align="center" stylecode="Rrule" valign="top">↓ Ganciclovir<br/>↑ Didanosine<br/>
</td>
<td align="center" stylecode="Rrule" valign="top">Patients should be closely monitored for didanosine toxicity<br/>
</td>
</tr>
</tbody>
</table>